Clinical Trial Update: Orthotopic Liver Transplant (OLT) Recipients With Hepatitis C Virus (HCV) Under Preemptive Treatment [Phase 4]

View source ↗

Summary

The Phase 4 clinical trial evaluating preemptive treatment in orthotopic liver transplant recipients with hepatitis C has been withdrawn.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hepatitis C

Snippet

Sponsor: The University of Texas Health Science Center, Houston | Conditions: Hepatitis C | Phase 4 | Status: WITHDRAWN